
Clinical Trials Matching Software Market by Software Type (Patient Recruitment & Enrollment, Protocol Design & Optimization, Site Selection & Feasibility Assessment), Functionality (Matchmaking Algorithms, Patient Database Management, Protocol Optimizatio
Description
Clinical Trials Matching Software Market by Software Type (Patient Recruitment & Enrollment, Protocol Design & Optimization, Site Selection & Feasibility Assessment), Functionality (Matchmaking Algorithms, Patient Database Management, Protocol Optimization), End-Use, Deployment - Global Forecast 2024-2030
The Clinical Trials Matching Software Market size was estimated at USD 219.51 million in 2023 and expected to reach USD 248.18 million in 2024, at a CAGR 13.54% to reach USD 534.07 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trials Matching Software Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trials Matching Software Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Clinical Trials Matching Software Market, highlighting leading vendors and their innovative profiles. These include Advarra Technology Solutions, Antidote Technologies, Inc., Aris Global, BSI Business Systems Integration AG, Clario, Clinical Trials Mobile Application, Cytel Inc., Evidation Health, Inc., HCL Technologies Limited, HealthMatch Pty. Ltd., IBM Clinical development, Inspirata, Inc., International Business Machines Corporation, IQVIA Holdings, Inc., Microsoft Corporation, SSS International Clinical Research, Teckro, Inc., Tempus Labs, and TrialSpark, Inc..
Market Segmentation & Coverage
This research report categorizes the Clinical Trials Matching Software Market to forecast the revenues and analyze trends in each of the following sub-markets:
Software Type
Patient Recruitment & Enrollment
Protocol Design & Optimization
Site Selection & Feasibility Assessment
Trial Planning & Management
Functionality
Matchmaking Algorithms
Patient Database Management
Protocol Optimization
End-Use
CROs
Medical Device Firms
Pharmaceuticals & Biotechnology Companies
Deployment
Cloud & Web Based
On-Premise
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Clinical Trials Matching Software Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trials Matching Software Market?
3. What are the technology trends and regulatory frameworks in the Clinical Trials Matching Software Market?
4. What is the market share of the leading vendors in the Clinical Trials Matching Software Market?
5. Which modes and strategic moves are suitable for entering the Clinical Trials Matching Software Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
181 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Clinical Trials Matching Software Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising need for clinical trials in healthcare domain
- 5.1.1.2. Significant requirement for precision oncology
- 5.1.1.3. Potential demand for virtual trials and automation in the healthcare sector
- 5.1.2. Restraints
- 5.1.2.1. Concern associated with accuracy of clinical trial results
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing research and development activities in pharmaceuticals and biotechnology scetor
- 5.1.3.2. Integration of artificial intelligence in clinical trial matching services
- 5.1.4. Challenges
- 5.1.4.1. Dearth of skilled and experienced professionals
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Clinical Trials Matching Software Market, by Software Type
- 6.1. Introduction
- 6.2. Patient Recruitment & Enrollment
- 6.3. Protocol Design & Optimization
- 6.4. Site Selection & Feasibility Assessment
- 6.5. Trial Planning & Management
- 7. Clinical Trials Matching Software Market, by Functionality
- 7.1. Introduction
- 7.2. Matchmaking Algorithms
- 7.3. Patient Database Management
- 7.4. Protocol Optimization
- 8. Clinical Trials Matching Software Market, by End-Use
- 8.1. Introduction
- 8.2. CROs
- 8.3. Medical Device Firms
- 8.4. Pharmaceuticals & Biotechnology Companies
- 9. Clinical Trials Matching Software Market, by Deployment
- 9.1. Introduction
- 9.2. Cloud & Web Based
- 9.3. On-Premise
- 10. Americas Clinical Trials Matching Software Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Clinical Trials Matching Software Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Clinical Trials Matching Software Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Advarra Technology Solutions
- 14.1.2. Antidote Technologies, Inc.
- 14.1.3. Aris Global
- 14.1.4. BSI Business Systems Integration AG
- 14.1.5. Clario
- 14.1.6. Clinical Trials Mobile Application
- 14.1.7. Cytel Inc.
- 14.1.8. Evidation Health, Inc.
- 14.1.9. HCL Technologies Limited
- 14.1.10. HealthMatch Pty. Ltd.
- 14.1.11. IBM Clinical development
- 14.1.12. Inspirata, Inc.
- 14.1.13. International Business Machines Corporation
- 14.1.14. IQVIA Holdings, Inc.
- 14.1.15. Microsoft Corporation
- 14.1.16. SSS International Clinical Research
- 14.1.17. Teckro, Inc.
- 14.1.18. Tempus Labs
- 14.1.19. TrialSpark, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. CLINICAL TRIALS MATCHING SOFTWARE MARKET RESEARCH PROCESS
- FIGURE 2. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2023 VS 2030
- FIGURE 3. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CLINICAL TRIALS MATCHING SOFTWARE MARKET DYNAMICS
- FIGURE 7. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2023 VS 2030 (%)
- FIGURE 8. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
- FIGURE 10. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 12. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
- FIGURE 14. CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. CLINICAL TRIALS MATCHING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. CLINICAL TRIALS MATCHING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.